HubSpot: Believe The Transition, But Wait For Confirmation

Daniel James280 FollowersFollow5ShareSavePlay(9min)CommentsSummaryHubSpot has reset to a mid-growth SaaS valuation, with ongoing revenue and customer growth and a strategic push upmarket.Q4 and FY2025 results beat expectations; net revenue retention improved to 105% in Q4, with management guiding for further gains in 2026.AI is increasingly embedded in HUBS’s core products, with growing adoption of Breeze Assistant and agents and a $40.35M AI R&D investment.I rate HUBS a Hold, as the current valuation already reflects improved fundamentals; a clear Buy would require margin expansion, stronger AI monetization, and higher retention.

Getty Images HubSpot (HUBS) has undergone a significant reset over the last year, with the stock down more than 60%, putting its valuation closer in line with peers. The market is starting to price the company as a stable, mid-growth software providerThis article was written byDaniel James280 FollowersFollowI am a part-time investor interested in equities, ETFs, macro, and emerging markets.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.